In AML, metformin can block the expression of proto-oncogenes by inhibiting mTOR, inhibiting the proliferation of G0/G1 or S-G2/M cells, interfering with cancer cell proliferation and colony formation activity, and inducing apoptosis but not affecting the proliferation and differentiation of normal HSCs [20]. The gene discussed is MTOR; the disease is acute myeloid leukemia.